GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
1-Year Return
32.47%
This Quarter Return
-0.06%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$2.63B
AUM Growth
+$5.56M
(+0.21%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
23.88%
Holding
516
New
129
Increased
23
Reduced
94
Closed
60
Top Buys
| 1 |
Coupang
CPNG
|
$105M |
| 2 |
Sea Limited
SE
|
$86.1M |
| 3 |
Maravai LifeSciences
MRVI
|
$58M |
| 4 |
Opendoor
OPEN
|
$57.5M |
| 5 |
VICI Properties
VICI
|
$56.8M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
$70.5M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$69.4M |
| 3 |
Guardant Health
GH
|
$54.3M |
| 4 |
XPO
XPO
|
$46.3M |
| 5 |
Luminar Technologies
LAZR
|
$43.9M |
Sector Composition
| 1 | Technology | 24.83% |
| 2 | Financials | 19.36% |
| 3 | Consumer Discretionary | 18.52% |
| 4 | Healthcare | 10.16% |
| 5 | Real Estate | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Oscar Health
OSCR
$5.02B
| $261K | 0.01% |
15,000
-235,000
| -94% | -$4.09M |
|
|
CNTA
427
Centessa Pharmaceuticals
CNTA
$2.11B
| $251K | 0.01% |
15,000
-10,000
| -40% | -$167K |
|
428
CVRx
CVRX
$204M
| $248K | 0.01% |
15,000
-11,000
| -42% | -$182K |
|
|
LENZ
429
LENZ Therapeutics
LENZ
$1.2B
| $246K | 0.01% |
2,143
-3,571
| -62% | -$410K |
|
430
Neuropace
NPCE
$322M
| $238K | 0.01% |
15,000
-34,999
| -70% | -$555K |
|
431
Nuvalent
NUVL
$5.83B
| $226K | 0.01% |
+10,000
| New | +$226K |
|
432
Lyell Immunopharma
LYEL
$233M
| $222K | 0.01% |
750
-4,250
| -85% | -$1.26M |
|
|
TIGR
433
UP Fintech Holding
TIGR
$2.18B
| $212K | 0.01% |
20,000
-242,697
| -92% | -$2.57M |
|
|
AKYA
434
DELISTED
Akoya BioSciences
AKYA
| $209K | 0.01% |
15,000
-5,000
| -25% | -$69.7K |
|
435
Tourmaline Bio
TRML
$687M
| $203K | 0.01% |
1,500
+500
| +50% | +$67.7K |
|
|
AMAM
436
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $203K | 0.01% |
15,000
-25,000
| -63% | -$338K |
|
437
Compass
COMP
$5.07B
| $199K | 0.01% |
15,000
-110,000
| -88% | -$1.46M |
|
|
ARYE
438
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $198K | 0.01% |
+20,000
| New | +$198K |
|
|
ZY
439
DELISTED
Zymergen Inc. Common Stock
ZY
| $198K | 0.01% |
15,000
-17,612
| -54% | -$232K |
|
|
OMIC
440
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $168K | 0.01% |
500
+167
| +50% | +$56.1K |
|
|
ARYD
441
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $151K | 0.01% |
15,000
| – | – |
|
|
RERE
442
ATRenew
RERE
$968M
| $150K | 0.01% |
15,000
-115,000
| -88% | -$1.15M |
|
|
ZH
443
Zhihu
ZH
$428M
| $138K | 0.01% |
2,500
-97,500
| -98% | -$5.38M |
|
|
TUYA
444
Tuya Inc
TUYA
$1.53B
| $136K | 0.01% |
15,000
-485,000
| -97% | -$4.4M |
|
445
RxSight
RXST
$364M
| $127K | ﹤0.01% |
+10,000
| New | +$127K |
|
|
CNVY
446
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $126K | ﹤0.01% |
15,000
-185,000
| -93% | -$1.55M |
|
447
FTC Solar
FTCI
$93.4M
| $117K | ﹤0.01% |
1,500
-1,000
| -40% | -$78K |
|
|
DIDI
448
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $117K | ﹤0.01% |
15,000
-1,485,000
| -99% | -$11.6M |
|
449
Absci
ABSI
$368M
| $116K | ﹤0.01% |
+10,000
| New | +$116K |
|
450
Sera Prognostics
SERA
$127M
| $111K | ﹤0.01% |
+10,000
| New | +$111K |
|